John P. Longenecker's most recent trade in Pacira BioSciences Inc was a trade of 7,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | John P. Longenecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2022 | 7,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | John P. Longenecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.81 per share. | 03 Mar 2022 | 7,000 | 25,823 (0%) | 0% | 10.8 | 75,670 | Common Stock |
| Pacira BioSciences Inc | John P. Longenecker | Director | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 03 Mar 2022 | 7,000 | 18,823 (0%) | 0% | 71.7 | 502,145 | Common Stock |
| Pacira BioSciences Inc | John P. Longenecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | John P. Longenecker | Director | Sale of securities on an exchange or to another person at price $ 72.26 per share. | 01 Mar 2021 | 5,000 | 17,757 (0%) | 0% | 72.3 | 361,300 | Common Stock |
| Pacira BioSciences Inc | John P. Longenecker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.98 per share. | 01 Mar 2021 | 5,000 | 22,757 (0%) | 0% | 14.0 | 69,900 | Common Stock |